Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 48: 208-209, 2002;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tagliaro, F.
Right arrow Articles by De Buyzere, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tagliaro, F.
Right arrow Articles by De Buyzere, M. L.
(Clinical Chemistry. 2002;48:208-209.)
© 2002 American Association for Clinical Chemistry, Inc.


Letters

Caveats in Carbohydrate-deficient Transferrin Determination

Franco Tagliaro1a, Federica Bortolotti2, Romolo M. Dorizzi3 and Mario Marigo2

1 Institute of Forensic Medicine, Catholic University of the Sacred Heart, Largo Francesco Vito 1, 00168 Rome, Italy

2 Department of Public Medicine and Health, Unit of Forensic Medicine, University of Verona, 37134 Verona, Italy

3 Clinical Chemistry and Hematology Laboratory, Hospital of Verona, 37126 Verona, Italy

aAuthor for correspondence. Fax 39-045-505259; e-mail franco.tagliaro@univr.it.s.


To the Editor:

Carbohydrate-deficient transferrin (CDT) refers to a group of minor isoforms of transferrin that, according to most authors, includes asialo-, monosialo-, and disialo-Fe2-transferrin (1). CDT is a widely used marker of chronic alcohol abuse in Europe and, after its recent approval by the Food and Drug Administration, a candidate to become a popular diagnostic tool in the US (2). Arndt (1) recently concluded that "CDT is the most specific marker of chronic alcohol abuse to date". Its specificity, however, is affected by the choice of analytical method, which must selectively determine only the CDT components, without interference from the other transferrin glycoforms (trisialo-, tetrasialo-, pentasialo-, and hexasialo-Fe2-transferrin), which are present in large excess.

Interference from trisialo-Fe2-transferrin has been reported for most commercial CDT tests, which are based on anion-exchange microchromatographic separations followed by immunoassays. Unfortunately, much of the literature does not report any correlation between trisialo-transferrin and alcohol intake (3). Moreover, Dibbelt (4) recently demonstrated by HPLC that increased relative concentrations of disialo- and asialo-transferrin associated with alcohol abuse are not correlated with increased trisialo-transferrin concentrations and consequently stated that "trisialo-transferrin is obviously of no diagnostic value, I strongly recommend not including this . . . [Full Text of this Article]


References

Joris R. Delanghe4b, Birgitte Wuyts4 and Marc L. De Buyzere4

4 Department of Clinical Chemistry, University Hospital Gent, De Pintelaan 185, 9000 Gent, Belgium

bAuthor for correspondence. Fax 32-9-240-49-85; e-mail joris.delanghe@rug.ac.be.


References




The following articles in journals at HighWire Press have cited this article:


Home page
Alcohol AlcoholHome page
P. Anttila, K. Jarvi, J. Latvala, and O. Niemela
METHOD-DEPENDENT CHARACTERISTICS OF CARBOHYDRATE-DEFICIENT TRANSFERRIN MEASUREMENTS IN THE FOLLOW-UP OF ALCOHOLICS
Alcohol Alcohol., January 1, 2004; 39(1): 59 - 63.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
P. Anttila, K. Jarvi, J. Latvala, J. E. Blake, and O. Niemela
DIAGNOSTIC CHARACTERISTICS OF DIFFERENT CARBOHYDRATE-DEFICIENT TRANSFERRIN METHODS IN THE DETECTION OF PROBLEM DRINKING: EFFECTS OF LIVER DISEASE AND ALCOHOL CONSUMPTION
Alcohol Alcohol., September 1, 2003; 38(5): 415 - 420.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
F. J. Legros, V. Nuyens, M. Baudoux, K. Zouaoui Boudjeltia, J.-L. Ruelle, J. Colicis, F. Cantraine, and J.-P. Henry
Use of Capillary Zone Electrophoresis for Differentiating Excessive from Moderate Alcohol Consumption
Clin. Chem., March 1, 2003; 49(3): 440 - 449.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
F. J. Legros, V. Nuyens, E. Minet, P. Emonts, K. Z. Boudjeltia, A. Courbe, J.-L. Ruelle, J. Colicis, F. de L'Escaille, and J.-P. Henry
Carbohydrate-deficient Transferrin Isoforms Measured by Capillary Zone Electrophoresis for Detection of Alcohol Abuse
Clin. Chem., December 1, 2002; 48(12): 2177 - 2186.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Association for Clinical Chemistry.